Concepedia

Publication | Open Access

Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial

23

Citations

27

References

2024

Year

References

YearCitations

Page 1